cannabis indica

Índice completo — página 25 de 77

Estudos 2.401 a 2.500 de 7.640, ordenados do mais recente ao mais antigo — nesta página, publicações de 2021. Para buscar por termo ou combinar filtros, use o acervo com busca.

Estudos 2.401 a 2.500

  1. 2021

    Modulation of striatal functional connectivity differences in adults with and without autism spectrum disorder in a single-dose randomized trial of cannabidivarin

    FavorávelEnsaio Clínico Duplo-CegoAutismoCanabidivarina (CBDV)
  2. 2021

    Modulatory effect of 2-arachidonoylglycerol on voltage-gated sodium currents in rat caudate nucleus neurons with kainic acid-induced injury

    FavorávelEstudo em AnimaisExcitotoxicidade2-Araquidonoilglicerol (2-AG)
  3. 2021

    Modulatory Potential of Cannabidiol on the Opioid-Induced Inflammatory Response

    FavorávelMetanáliseInflamaçãoDependência — Opioides
  4. 2021

    Molecular Mechanisms for the Inflammation-Resolving Actions of Lenabasum

  5. 2021

    Momentary coping and marijuana use in treated adults: Exploring mechanisms of treatment

    FavorávelEnsaio ClínicoDependência QuímicaDependência — Cannabis
  6. 2021

    Monoacylglycerol Lipase Inhibition in Tourette Syndrome: A 12-Week, Randomized, Controlled Study

    DesfavorávelEnsaio Clínico Duplo-CegoTDA e TDAHTiques e Síndrome de TouretteTOCAnandamida (AEA)Tetraidrocanabinol (THC)+2
  7. 2021

    Monoacylglycerol Lipase Inhibition Using JZL184 Attenuates Paw Inflammation and Functional Deficits in a Mouse Model of Inflammatory Arthritis

    FavorávelEstudo em AnimaisArtriteArtrite — OsteoartriteMonoacilglicerol Lipase (MAGL)
  8. 2021

    Morbidity and mortality associated with prescription cannabinoid drug use in COPD

    DesfavorávelMetanáliseDPOC
  9. 2021

    Morphine Induces Upregulation of Neuronally Expressed CB2 Receptors in the Spinal Dorsal Horn of Rats

    FavorávelEstudo em AnimaisDorDor — Crônica
  10. 2021

    Motivational Interviewing for Cannabis Use Disorders: A Systematic Review and Meta-Analysis

    FavorávelEnsaio Clínico Duplo-CegoDependência QuímicaDependência — Cannabis
  11. 2021

    Multiple clinical risks for cannabis users during the COVID-19 pandemic

    DesfavorávelMetanáliseCOVID-19
  12. 2021

    Myrcene—What Are the Potential Health Benefits of This Flavouring and Aroma Agent?

    FavorávelMetanáliseDorCâncerInflamaçãoEndocanabinoide (não especificado)+10
  13. 2021

    Myrtenal and β-caryophyllene oxide screened from Liquidambaris Fructus suppress NLRP3 inflammasome components in rheumatoid arthritis

  14. 2021

    N-arachidonoyl dopamine inhibits epithelial-mesenchymal transition of breast cancer cells through ERK signaling and decreasing the cellular cholesterol

    FavorávelEstudo LaboratorialCâncerCâncer — MamaN-Araquidonoil Dopamina (NADA)
  15. 2021

    Nabiximols and botulinum toxin injections for patients with multiple sclerosis: efficacy on spasticity and spasms in a single-centre experience

    FavorávelMetanáliseEsclerose MúltiplaTHC:CBD Farmacêutico
  16. 2021

    Nabiximols in Chronic Neuropathic Pain: A Meta-Analysis of Randomized Placebo-Controlled Trials

    FavorávelMetanálise ClínicaDorDor — CrônicaTHC:CBD Farmacêutico
  17. 2021

    Natural and Synthetic Cannabinoids: Pharmacology, Uses, Adverse Drug Events, and Drug Interactions

  18. 2021

    Natural Cannabinoids as Templates for Sleep Disturbances Treatments

    FavorávelMetanáliseInsônia e Distúrbios do Sono
  19. 2021

    Natural Products with Potential for Nonhormonal Male Contraception

    FavorávelMetanáliseGestaçãoOutros Compostos Relacionados
  20. 2021

    Near-Fatal Spice Intoxication of a Toddler

  21. 2021

    Nephrologist Views Regarding Cannabinoid Use in Advanced Chronic Kidney Disease and Dialysis: A Survey

    FavorávelMetanáliseCâncerInsuficiência RenalDoença Renal Crônica+4
  22. 2021

    Neurobiological Processes Induced by Aerobic Exercise through the Endocannabinoidome

  23. 2021

    Neurodevelopmental Effects of Cannabis Use in Adolescents and Emerging Adults with ADHD: A Systematic Review

    InconclusivoMetanáliseTDA e TDAH
  24. 2021

    Neuropharmacological Effects of the Main Phytocannabinoids: A Narrative Review

    InconclusivoMetanáliseDorAnsiedadeDor — Crônica+4
  25. 2021

    Neuroprotection with the cannabigerol quinone derivative VCE-003.2 and its analogs CBGA-Q and CBGA-Q-Salt in Parkinson's disease using 6-hydroxydopamine-lesioned mice

    FavorávelEstudo em AnimaisDoença de ParkinsonCanabigerol (CBG)
  26. 2021

    Neuroprotective and neurotoxic effects of endocannabinoid-like compounds, N-arachidonoyl dopamine and N-docosahexaenoyl dopamine in differentiated cultures of induced pluripotent stem cells derived from patients with Parkinson's disease

    FavorávelEstudo LaboratorialDoença de ParkinsonN-Araquidonoil Dopamina (NADA)
  27. 2021

    Neuroprotective and Symptomatic Effects of Cannabidiol in an Animal Model of Parkinson’s Disease

    FavorávelEstudo em AnimaisDoença de Parkinson
  28. 2021

    Neuroprotective Effect of Cannabidiol Against Hydrogen Peroxide in Hippocampal Neuron Culture

    FavorávelEstudo LaboratorialEstresse Oxidativo
  29. 2021

    Neuroprotective effect of α-pinene self-emulsifying nanoformulation against 6-OHDA induced neurotoxicity on human SH-SY5Y cells and its in vivo validation for anti-Parkinson's effect

    FavorávelEstudo em AnimaisEstresse OxidativoDoenças NeurodegenerativasDoença de Parkinson
  30. 2021

    Neuroprotective Effects of Cannabidiol but Not Δ9-Tetrahydrocannabinol in Rat Hippocampal Slices Exposed to Oxygen-Glucose Deprivation: Studies with Cannabis Extracts and Selected Cannabinoids

  31. 2021

    Neuroprotective Phytochemicals in Experimental Ischemic Stroke: Mechanisms and Potential Clinical Applications

    FavorávelMetanáliseAVC
  32. 2021

    Neuroprotective Potential of Limonene and Limonene Containing Natural Products

    FavorávelMetanáliseAnsiedadeEpilepsiaDoenças Neurodegenerativas+3
  33. 2021

    New Insights in the Involvement of the Endocannabinoid System and Natural Cannabinoids in Nicotine Dependence

  34. 2021

    New Insights on Hemp Oil Enriched in Cannabidiol: Decarboxylation, Antioxidant Properties and In Vitro Anticancer Effect

    FavorávelEstudo LaboratorialCâncer
  35. 2021

    New Pharmacological Targets for the Treatment of Schizophrenia: A Literature Review

    FavorávelMetanálisePsicoseEsquizofreniaCBD Farmacêutico
  36. 2021

    New possibilities for neuroprotection in neonatal hypoxic-ischemic encephalopathy

  37. 2021

    New Psychoactive Substances and Suicidality: A Systematic Review of the Current Literature

  38. 2021

    New therapeutic approach in Dravet syndrome and Lennox-Gastaut syndrome with cannabidiol

  39. 2021

    No pain, all gain? Interim analyses from a longitudinal, observational study examining the impact of medical cannabis treatment on chronic pain and related symptoms

    FavorávelMetanáliseDorAnsiedadeDor — Crônica+1
  40. 2021

    Non-Cannabinoid Metabolites of Cannabis sativa L. with Therapeutic Potential

    FavorávelMetanáliseCOVID-19
  41. 2021

    Normalization of mediotemporal and prefrontal activity, and mediotemporal-striatal connectivity, may underlie antipsychotic effects of cannabidiol in psychosis

    FavorávelMetanálisePsicose
  42. 2021

    Nose-to-brain delivery of borneol modified tanshinone IIA nanoparticles in prevention of cerebral ischemia/reperfusion injury

    FavorávelEstudo LaboratorialDoenças Cardiovasculares (DCV)AVCLesão de Reperfusão
  43. 2021

    Novel cannabidiol aspartame combination treatment (JW-100) significantly reduces ISGA score in atopic dermatitis: Results from a randomized double-blinded placebo-controlled interventional study

    FavorávelEnsaio Clínico Duplo-CegoDoenças de Pele
  44. 2021

    Novel cannabidiol−carbamate hybrids as selective BuChE inhibitors: Docking-based fragment reassembly for the development of potential therapeutic agents against Alzheimer's disease

    FavorávelMetanáliseDoença de Alzheimer
  45. 2021

    Novel CBG Derivatives Can Reduce Inflammation, Pain and Obesity

    FavorávelEstudo em AnimaisDorInflamaçãoDor — CrônicaCanabigerol (CBG)+1
  46. 2021

    Novel Knowledge-Based Transcriptomic Profiling of Lipid Lysophosphatidylinositol-Induced Endothelial Cell Activation

  47. 2021

    Novel selective agonist of GPR18, PSB-KK-1415 exerts potent anti-inflammatory and anti-nociceptive activities in animal models of intestinal inflammation and inflammatory pain

  48. 2021

    Novel Δ8‐Tetrahydrocannabinol Vaporizers Contain Unlabeled Adulterants, Unintended Byproducts of Chemical Synthesis, and Heavy Metals

  49. 2021

    Nurse home visiting and prenatal substance use in a socioeconomically disadvantaged population in British Columbia: analysis of prenatal secondary outcomes in an ongoing randomized controlled trial

    FavorávelEnsaio Clínico Duplo-CegoGestaçãoAlterações Cerebrais Neonatais
  50. 2021

    Observed Impact of Long-term Consumption of Oral Cannabidiol on Liver Function in Healthy Adults

    InconclusivoMetanáliseFibroseEsteatose HepáticaFibrose — Hepática (Cirrose)
  51. 2021

    Olorinab (APD371), a peripherally acting, highly selective, full agonist of the cannabinoid receptor 2, reduces colitis-induced acute and chronic visceral hypersensitivity in rodents

  52. 2021

    Opioid and healthcare service use in medical cannabis patients with chronic pain: a prospective study

    FavorávelMetanáliseDorDor — CrônicaDependência — Opioides
  53. 2021

    Opioid Prescribing in Canada following the Legalization of Cannabis: A Clinical and Economic Time-Series Analysis

    FavorávelMetanáliseDorDor — CrônicaDependência — Opioides
  54. 2021

    Opioid use in medical cannabis authorization adult patients from 2013 to 2018: Alberta, Canada

    FavorávelMetanáliseDorDependência QuímicaDor — Crônica+1
  55. 2021

    Opioid-sparing effects of medical cannabis or cannabinoids for chronic pain: a systematic review and meta-analysis of randomised and observational studies

    InconclusivoMetanáliseDorDor — CrônicaDependência — Opioides+4
  56. 2021

    Opportunities, Challenges and Pitfalls of Using Cannabidiol as an Adjuvant Drug in COVID-19

    FavorávelMetanáliseCOVID-19
  57. 2021

    Opposite Roles for Cannabidiol and δ-9-Tetrahydrocannabinol in Psychotomimetic Effects of Cannabis Extracts: A Naturalistic Controlled Study

    FavorávelEnsaio Clínico Duplo-CegoPsicoseEsquizofrenia
  58. 2021

    Oral Cannabinoid Preparations for the Treatment of Chronic Migraine: A Retrospective Study

    FavorávelEnsaio ClínicoEnxaquecaCanabinol (CBN)
  59. 2021

    Oral CBD-rich cannabis induces clinical but not endoscopic response in patients with Crohn's disease, a randomized controlled trial

    FavorávelEnsaio Clínico Duplo-CegoDII — Doença Inflamatória IntestinalDII — Doença de CrohnQualidade de Vida
  60. 2021

    Oral efficacy of Δ(9)-tetrahydrocannabinol and cannabidiol in a mouse neuropathic pain model

    FavorávelEstudo em AnimaisDorDor — CrônicaDor — Neuropatia Periférica
  61. 2021

    Orally Active Peptide Vector Allows Using Cannabis to Fight Pain While Avoiding Side Effects

    FavorávelEstudo LaboratorialDorDor — Crônica
  62. 2021

    Orally administered cannabidiol does not produce false-positive tests for Δ9 -tetrahydrocannabinol on the Securetec DrugWipe® 5S or Dräger DrugTest® 5000

    InconclusivoEnsaio Clínico Duplo-CegoEfeitos Adversos da CannabisCanabigerol (CBG)Canabinol (CBN)
  63. 2021

    Orexinergic descending inhibitory pathway mediates linalool odor-induced analgesia in mice

    FavorávelEstudo em AnimaisDorDor — Aguda
  64. 2021

    Overview of Synthetic Cannabinoids ADB-FUBINACA and AMB-FUBINACA: Clinical, Analytical, and Forensic Implications

  65. 2021

    Oxidative Stress and Its Consequences in the Blood of Rats Irradiated with UV: Protective Effect of Cannabidiol

    FavorávelEstudo em AnimaisCâncerInflamaçãoEstresse Oxidativo+4
  66. 2021

    P.0835 Synergistic effects of lysergic acid diethylamide (LSD) and cannabidiol (CBD)

    FavorávelEstudo em AnimaisDepressão
  67. 2021

    Pain Profiles among Young Adult Cannabis Users: An Analysis of Antecedent Factors and Distal Outcomes

    FavorávelMetanáliseDorDor — CrônicaInsônia e Distúrbios do Sono+1
  68. 2021

    Pain, cannabis use, and physical and mental health indicators among veterans and nonveterans: results from the National Epidemiologic Survey on Alcohol and Related Conditions-III

    DesfavorávelMetanáliseDorDependência — CannabisAnsiedade+3
  69. 2021

    Palmitoylethanolamide (PEA) in the treatment of neuropathic pain: a case study

  70. 2021

    Palmitoylethanolamide and hemp oil extract exert synergistic anti-nociceptive effects in mouse models of acute and chronic pain

    FavorávelEstudo em AnimaisDorDor — CrônicaDor — Aguda
  71. 2021

    Palmitoylethanolamide and Its Biobehavioral Correlates in Autism Spectrum Disorder: A Systematic Review of Human and Animal Evidence

  72. 2021

    Palmitoylethanolamide for sleep disturbance. A double-blind, randomised, placebo-controlled interventional study

    FavorávelEnsaio Clínico Duplo-CegoInsônia e Distúrbios do SonoPalmitoiletanolamida (PEA)
  73. 2021

    Palmitoylethanolamide Modulation of Microglia Activation: Characterization of Mechanisms of Action and Implication for Its Neuroprotective Effects

    FavorávelEstudo LaboratorialInflamaçãoPalmitoiletanolamida (PEA)
  74. 2021

    Palmitoylethanolamide: A Natural Compound for Health Management

    FavorávelMetanáliseDorInflamaçãoDor — CrônicaPalmitoiletanolamida (PEA)+1
  75. 2021

    Parent SMART (Substance Misuse in Adolescents in Residential Treatment): Pilot randomized trial of a technology-assisted parenting intervention

  76. 2021

    Patient-reported outcomes in those consuming medical cannabis: a prospective longitudinal observational study in chronic pain patients

    FavorávelMetanáliseDorDor — Crônica
  77. 2021

    Patterns of brain function associated with cannabis cue-reactivity in regular cannabis users: a systematic review of fMRI studies

    InconclusivoMetanáliseDependência QuímicaDependência — Cannabis
  78. 2021

    Patterns of Medical Cannabis Use among Patients Diagnosed with Multiple Sclerosis

    FavorávelMetanáliseEsclerose Múltipla
  79. 2021

    Pediatric cannabis intoxication trends in the pre and post-legalization era

    DesfavorávelMetanáliseEfeitos Adversos da Cannabis
  80. 2021

    Peptide targeting of lysophosphatidylinositol-sensing GPR55 for osteoclastogenesis tuning

  81. 2021

    Perceived Efficacy, Reduced Prescription Drug Use, and Minimal Side Effects of Cannabis in Patients with Chronic Orthopedic Pain

    FavorávelMetanáliseDorDor — Crônica
  82. 2021

    Perceptions about cannabis use during pregnancy: a rapid best-framework qualitative synthesis

    InconclusivoMetanáliseGestação
  83. 2021

    Peri-Pregnancy Cannabis Use and Autism Spectrum Disorder in the Offspring: Findings from the Study to Explore Early Development

    DesfavorávelMetanáliseGestaçãoAutismoAlterações Cerebrais Neonatais
  84. 2021

    Perinatal Cannabis Exposures and Autism Spectrum Disorders

    InconclusivoMetanáliseNáusea e VômitoGestaçãoAutismoCanabicromeno (CBC)+1
  85. 2021

    Periodontal status in cannabis smokers. A systematic review

    DesfavorávelMetanáliseDoença PeriodontalCáries
  86. 2021

    Perioperative Cannabis as a Potential Solution for Reducing Opioid and Benzodiazepine Dependence

    FavorávelMetanáliseDorDependência QuímicaCâncer+4
  87. 2021

    Perioperative Pain and Addiction Interdisciplinary Network (PAIN): consensus recommendations for perioperative management of cannabis and cannabinoid-based medicine users by a modified Delphi process

    InconclusivoMetanáliseDorNáusea e VômitoDor — Aguda
  88. 2021

    Persistence of Δ-9-Tetrahydrocannabinol in Human Breast Milk

    FavorávelEnsaio ClínicoGestação
  89. 2021

    Persistent Cannabis Abuse and Risk for Hospitalization for Acute Pancreatitis: A Cross-Sectional Study in United States Hospitals

    DesfavorávelMetanálisePancreatite
  90. 2021

    Persistent exposure to Δ 9- tetrahydrocannabinol during adolescence does not affect nociceptive responding in adult mice

    InconclusivoEstudo em AnimaisDorInflamação
  91. 2021

    Perspectives of pediatric oncologists and palliative care physicians on the therapeutic use of cannabis in children with cancer

    FavorávelMetanáliseDorCâncerDor — Crônica+8
  92. 2021

    Pharmacokinetics and effects on arachidonic acid metabolism of low doses of cannabidiol following oral administration to horses

    InconclusivoEstudo em AnimaisAplicações Veterinárias
  93. 2021

    Pharmacokinetics and Perceptions of Children and Young Adults Using Cannabis for Attention-Deficit/Hyperactivity Disorder and Oppositional Defiant Disorder: Protocol for a Mixed Methods Proof-of-Concept Study

  94. 2021

    Pharmacokinetics and Pharmacodynamics of the Synthetic Cannabinoid, 5F-MDMB-PICA, in Male Rats

    DesfavorávelEstudo em AnimaisIntoxicação por Cannabis SintéticaCanabinoides Sintéticos 5F-x
  95. 2021

    Pharmacokinetics of cannabidiol in children with refractory epileptic encephalopathy

    InconclusivoEnsaio ClínicoEpilepsiaEncefalite e Mielite
  96. 2021

    Pharmacologic Antagonization of Cannabinoid Receptor 1 Improves Cholestasis in Abcb4-/- Mice

  97. 2021

    Pharmacological inhibition of the primary endocannabinoid producing enzyme, DGL-α, induces autism spectrum disorder-like and co-morbid phenotypes in adult C57BL/J mice

    FavorávelEstudo em AnimaisAutismoOutros Compostos Relacionados
  98. 2021

    Pharmacological Properties of the Plant-Derived Natural products Cannabinoids and Implications for Cardiovascular Health

    InconclusivoMetanáliseDoenças Cardiovasculares (DCV)InfartoAterosclerose
  99. 2021

    Pharmacology, Clinical Effects, and Therapeutic Potential of Cannabinoids for Gastrointestinal and Liver Diseases

  100. 2021

    Pharmacotherapies for cannabis use disorder: A systematic review and network meta-analysis